Revelation Biosciences (REVB) Stock Insights

REVB price $3.61 -0.12 -3.32%

Ticker
REVB
Price
$3.61
Change
-0.12 -3.32%
Market cap ?
$2.05M
Beta ?
-0.17
Sector
Healthcare
Industry
Biotechnology

Fair value

REVB fair value $938.60. Price $3.61. Price is 100% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare REVB

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-6.16——
2026-08-07-6.09-6.12——
2026-05-07-2.71-8.05——
2026-03-05-1.65-9.87——
2025-11-07-7.08-9.38——
2025-08-08-28.04-31.22——
2025-05-09-25.32-48.16——
2025-03-20-59.76-4.83——
2024-11-08-5.88-19.88——
2024-08-09-295.71-12.67——
2024-05-20-17.22-37.66——
2024-03-28-58.31-96.39——
2023-11-09-2,364.20-2.10——
2023-08-14-1.75-2.80——
2023-05-2219.53-4.55——
2023-03-30-10,206.43-5,880.00——
2022-11-10-441.00-22.05——
2022-08-15-24,194.44-28,226.85——
2022-05-16-115.15-34.30——
2022-04-15-45,988.67———
2021-10-29-56,905.45———
2021-08-23-46,160.38———
2021-06-22-48,839.28———
2021-03-31-20,757.59———
2020-11-16-10.57———
2020-01-284.55———
2019-10-244.834.76——
2019-07-244.554.48——
2019-04-294.344.27——
2019-01-294.134.27——
2018-11-094.554.55——
2018-07-31————
2018-04-27————
2018-02-08————

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-17Rolke JamesBuy208.08K——
2026-08-17Chawla Lakhmir SBuy32.01K——
2026-08-17Zygmont Chester Stanley IIIBuy208.07K——
2026-08-17Zygmont Chester Stanley IIIBuy208.07K——
2026-08-17Zygmont Chester Stanley IIISell208.07K——
2026-08-17ROPER JESSBuy32.01K——
2026-08-17CARVER JENNIFERBuy32.01K——
2026-04-30Rolke JamesSell10.12K$1.1311.43K
2026-04-30Zygmont Chester Stanley IIISell13.29K$1.1014.61K
2026-02-04Zygmont Chester Stanley IIISell13.10K$1.6521.61K
2026-02-03ROPER JESSSell1.59K$1.852.94K
2026-02-03Chawla Lakhmir SSell2.26K$1.854.18K
2026-02-03CARVER JENNIFERSell1.66K$1.873.11K
2026-02-03Rolke JamesSell8.52K$1.8615.85K
2026-01-08Rolke JamesBuy532.83K$0.90479.55K
2026-01-08Zygmont Chester Stanley IIIBuy78.14K$0.9070.33K
2026-01-08CARVER JENNIFERBuy41.98K$0.9037.78K
2026-01-08ROPER JESSBuy41.98K$0.9037.78K
2026-01-08Chawla Lakhmir SBuy41.98K$0.9037.78K
2025-10-29Chawla Lakhmir SBuy15.62K$1.2820.00K
2025-10-29Rolke JamesBuy390.61K$1.28499.99K
2025-10-29CARVER JENNIFERBuy15.62K$1.2820.00K
2025-10-29Zygmont Chester Stanley IIIBuy390.61K$1.28499.99K
2025-10-29ROPER JESSBuy15.62K$1.2820.00K
2025-02-11Chawla Lakhmir SBuy181$3.87700
2025-02-11CARVER JENNIFERBuy181$3.87700
2025-02-11ROPER JESSBuy181$3.87700
2025-02-11Rolke JamesBuy30.09K$3.87116.47K
2025-02-11Zygmont Chester Stanley IIIBuy15.05K$3.8758.24K
2025-02-11TIDMARSH GEORGE FBuy181$3.87700
2023-12-08TIDMARSH GEORGE FSell27.77K$0.5214.44K
2023-10-16TIDMARSH GEORGE FSell1.84K$0.651.20K
2023-10-16TIDMARSH GEORGE FSell10.96K$0.667.24K
2023-09-28TIDMARSH GEORGE FSell1.43K$0.69986
2023-09-27Chawla Lakhmir SOther0——
2023-09-18TIDMARSH GEORGE FSell4.00K$0.742.96K
2023-09-15TIDMARSH GEORGE FSell9.50K$0.736.93K
2023-09-14TIDMARSH GEORGE FSell12.00K$0.759.00K
2023-04-18TIDMARSH GEORGE FBuy25.00K$1.1629.00K
2023-04-17TIDMARSH GEORGE FBuy26.50K$1.1630.74K
2023-04-14TIDMARSH GEORGE FBuy6.36K$1.197.56K
2023-04-14ROPER JESSBuy6.36K$1.197.56K
2023-04-14LaBelle Curt HBuy6.36K$1.197.56K
2023-04-14CARVER JENNIFERBuy6.36K$1.197.56K
2023-02-25Zygmont Chester Stanley IIIBuy611$49.0029.94K
2023-02-25Rolke JamesBuy2.54K$49.00124.56K
2022-12-31AXA IM Prime Impact Master Fund I SCA SICAV-RAIFOther0——
2022-02-25TIDMARSH GEORGE FBuy20.00K$1.6032.00K
2022-02-09TIDMARSH GEORGE FBuy30.00K$2.5576.60K
2022-02-08TIDMARSH GEORGE FBuy1.00K$2.542.54K
2022-02-07TIDMARSH GEORGE FBuy42.10K$2.61109.78K
2022-02-04TIDMARSH GEORGE FBuy7.90K$2.3118.26K
2022-02-04TIDMARSH GEORGE FBuy2.00K$2.454.90K
2022-01-10Zygmont Chester Stanley IIIOther0——
2022-01-10Zygmont Chester Stanley IIIOther0——
2022-01-10Zygmont Chester Stanley IIIOther0——
2022-01-10Zygmont Chester Stanley IIISell15.59K——
2022-01-10TIDMARSH GEORGE FOther0——
2022-01-10TIDMARSH GEORGE FSell0——
2022-01-10TIDMARSH GEORGE FSell21.42K——
2022-01-10ROPER JESSSell21.42K——
2022-01-10Rolke JamesSell0——
2022-01-10Rolke JamesOther0——
2022-01-10Rolke JamesSell65.05K——
2022-01-10LaBelle Curt HSell21.42K——
2022-01-10CARVER JENNIFERSell0——
2022-01-10CARVER JENNIFERSell21.42K——
2022-01-10Feis LawrenceSell731.95K$10.207.47M
2021-10-13Feis LawrenceOther0——
2021-09-23GLAZER CAPITAL, LLCSell611.54K$10.086.16M
2021-09-22GLAZER CAPITAL, LLCSell5$10.0850
2021-09-21GLAZER CAPITAL, LLCSell43.00K$10.08433.44K
2021-03-11Carson William HowardSell0——
2020-12-30Fitzpatrick Sean HSell192.96K——
2020-12-30TYPALDOS ANDREASSell192.96K——
2020-11-09GLAZER CAPITAL, LLCSell5.00K$10.0050.00K
2020-10-16Fitzpatrick Sean HBuy83.45K——
2020-10-12GLAZER CAPITAL, LLCSell20$10.00200
2020-10-09GLAZER CAPITAL, LLCSell9.33K$10.0093.28K
2020-10-08GLAZER CAPITAL, LLCOther0——
2020-10-07TYPALDOS ANDREASOther0——
2020-10-07TYPALDOS ANDREASOther3.15M——
2020-10-07Fitzpatrick Sean HOther0——
2020-10-07Fitzpatrick Sean HOther3.15M——
2020-10-07Nicholson Robert DSell0——
2020-10-07Angelides KimonSell0——
2020-10-07Dobkin DavidSell0——
2020-10-07Dennis BarrySell0——
2020-10-07Hayes AnthonySell0——

Institutional holders

HolderSharesChangeChange %Value
No data yet.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Revelation Biosciences (REVB) Stock Insights

REVB$3.61-0.12 -3.32%

$2.05M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History